Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × Radiofrequency Ablation × Clear all

NCT02821754 2023-03-28

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Diabetes Mellitus, Insulin-Dependent, 12, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

NCT02468076 2016-05-11

IGNITE-1

Phase 2 Completed

18 enrolled

Gastrointestinal

Pancreatic Neoplasms, Cholangiocarcinoma, Jaundice, Obstructive